Gilder Gagnon Howe & Co’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.13M	Sell	77,164 -339,647	-81%	-$13.8M	0.03%	160
2025 Q1	$21.4M	Buy	416,811 +12,574	+3%	+$646K	0.28%	80
2024 Q4	$22.4M	Buy	404,237 +397,190	+5,636%	+$22M	0.24%	84
2024 Q3	$232K	Buy	+7,047	New	+$232K	﹤0.01%	246